Novonesis AS (Novonesis AS) Accounts Payable & Accrued Expense : $473 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Accounts Payable & Accrued Expense?

Novonesis AS's quarterly accounts payable & accrued expense increased from Jun. 2023 ($452 Mil) to Sep. 2023 ($481 Mil) but then declined from Sep. 2023 ($481 Mil) to Dec. 2023 ($473 Mil).

Novonesis AS's annual accounts payable & accrued expense increased from Dec. 2021 ($472 Mil) to Dec. 2022 ($512 Mil) but then declined from Dec. 2022 ($512 Mil) to Dec. 2023 ($473 Mil).

Novonesis AS Accounts Payable & Accrued Expense Historical Data

The historical data trend for Novonesis AS's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Accounts Payable & Accrued Expense Chart

Novonesis AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

433.30

412.40

472.12

511.75

472.87

Novonesis AS Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															511.75	487.18	452.13	480.99	472.87

Novonesis AS Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Novonesis AS (Novonesis AS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NZYM:Mexico NZYMBc:UK 0Q4U:UK NZYM B:Denmark NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Not Just Yogurt Anymore

By PRNewswire • 10-26-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso • 11-06-2019

Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row

By PRNewswire • 10-03-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research • 10-19-2023